Blood Treatment Apparatus with Control Unit Patent

The European Patent Office published patent application EP3618889A1 for Fresenius Medical Care Deutschland GmbH and Fresenius Medical Care Holdings, Inc., covering a blood treatment apparatus with a control unit configured for executing operating methods. The patent includes health informatics classifications (G16H 10/65, 20/17, 40/40, 40/63) and is designated across 31 European states.

Adhesive Preparation Management Method and Device

The European Patent Office published patent EP3437690A1 granting Nitto Denko Corporation rights to an adhesive preparation management method, module, and device. The patent, filed by inventors OKUMURA Keisuke and YOSHIOKA Ryoma, covers healthcare-related adhesive technologies classified under G16H 20/10 and various A61 medical device categories. The patent is validated in 41 designated contracting states across the European region.

Drug Dosing Recommendation Patent - Fresenius

European Patent Office published patent application EP3485405A1 for a drug dosing recommendation system filed by Fresenius Medical Care Deutschland GmbH. The patent application covers IPC classification G16H 20/10 and is designated for all EU member states including Germany, France, UK, Italy, Spain, and 25 additional extension states. Inventors are Carlo Barbieri and Flavio Mari.

CLOSED-LOOP BLOOD GLUCOSE CONTROL SYSTEMS AND METHODS

The European Patent Office published patent application EP3438858A1 for Diabeloop's closed-loop blood glucose control systems and methods. The patent covers automated insulin delivery technology combining continuous glucose monitoring with algorithmic processing to control blood glucose levels. Designated states include all EU member states plus other European countries.

Impedance Measurement System Patent

European Patent Office published patent EP3340874A1 for Impedimed Limited's impedance measurement system. The patent, filed by inventors Cosentino, Essex, and Miller, covers medical diagnostic devices using bioelectrical impedance analysis. The patent is designated for all European states including Germany, France, UK, Italy, and Spain.

Infusion Devices for Therapy Recommendations Based on Residual Amount of Active Fluid in the Body

The European Patent Office published patent application EP3297705A1 for Medtronic MiniMed, Inc., covering infusion devices that analyze residual amounts of active fluid in the body and provide therapy recommendations. The patent application lists six inventors and covers technology in the Health Informatics field (G16H) related to drug infusion systems. This A1 publication makes the application publicly available following EPO examination.

NCLAT Chennai Bench - Daily Cause List

NCLAT Chennai Bench published its daily cause list for April 2, 2026. The list includes cases scheduled for judgment delivery at 10:25 AM and admission hearings at 10:30 AM, covering insolvency proceedings (IA filings), stay applications, and liquidation matters. Cases involve various corporate entities including MS Biotech Pvt Ltd, Chettinad Coal Washeries Pvt Ltd, and SEW LSY Highways Ltd.

Draft Wastewater Permit for North Zumbro Sanitary Sewer District

The Minnesota Pollution Control Agency (MPCA) has issued a draft NPDES/SDS individual wastewater permit and Environmental Assessment Worksheet (EAW) for the proposed North Zumbro Sanitary Sewer District. The project would consolidate wastewater treatment for four communities—Goodhue, Wanamingo, Zumbrota, and Pine Island—into a single regional facility. MPCA is seeking public comment on both documents.

City of Duluth Settlement on Fish Kill

The Minnesota Pollution Control Agency reached a settlement with the City of Duluth requiring a $12,000 civil penalty and $190,000 in natural resource damages for a 2024 incident that killed approximately 2,300 fish in Tischer Creek. The incident occurred when city crews released 1.7 million gallons of treated drinking water containing chlorine and ammonia into the creek during reservoir sanitization.

Anti-Dumping Investigation on Unarmoured Building Cables from China

The CBSA initiated anti-dumping and countervailing investigations on March 16, 2026, concerning unarmoured building cables from China, following a complaint by PTI Cables Inc. The investigations were initiated under subsection 31(1) of the Special Import Measures Act after evidence showed that imports may have been dumped and subsidized, causing or threatening injury to the Canadian industry. The CBSA published the Statement of Reasons on March 31, 2026.